Product Reviews
Categories
- Alternative Medicine
- Cancer
- Acute Promyelocytic Leukemia
- Anal Cancer
- Bladder Cancer
- Breast cancer
- Colorectal cancer
- Endometrial Cancer
- Esophageal Cancer
- Gallbladder cancer
- Gastric Cancer
- Glioblastma
- Head and Neck Cancer
- Liver Cancer
- Lung Cancer
- Lymphoma
- Melanoma
- Nasopharyngeal Cancer
- Non-Hodgkin's Disease
- Ovarian Cancer
- Pancreatic Cancer
- Prostate cancer
- Renal Cancer
- Thyroid Cancer
- Cardiovascular disease
- Central Nervous System
- Constipation
- Diabetes
- Fatty Liver
- Irritable Bowel Syndrome
- Longevity
- Motherhood
- Obesity
- Others
- Psoriasis
- Respiratory Disease
- Rheumatoid Arthritis
Archives
Author Archives: wngai
First-Line Erlotinib Triples Progression-Free Survival in NSCLC in Chinese Population
First-line erlotinib (Tarceva) tripled the progression-free survival in advanced non–small cell lung carcinoma (NSCLC) patients who had endothelial growth factor receptor (EGFR)-activating mutation, according to the OPTIMAL study presented at the 35th European Society for Medical Oncology Congress. The study … Continue reading
Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer
Tagged carboplatin, endothelial growth factor receptor, erlotinib, gemcitabine, Gemzar, non–small cell lung carcinoma, NSCLC, OPTIMAL, progression-free, Survival, Tarceva
Comments Off on First-Line Erlotinib Triples Progression-Free Survival in NSCLC in Chinese Population
Diabetic Patients Are More Likely to Develop Pancreatitis
According to a study published online September 10th in Diabetes Care, patients with type 2 diabetes may have an increased risk of acute pancreatitis. Furthermore, the risk appears to be more pronounced at younger ages. Using data from The Health … Continue reading
Posted in Diabetes
Tagged Diabetes, Insulin, Metformin, Pancreatitis
Comments Off on Diabetic Patients Are More Likely to Develop Pancreatitis
Cetuximab (Erbitux) Reduces Disease Progression in Triple Negative Breast Cancer
Patients with triple negative breast cancer usually have poor prognosis, but a new drug might soon be available to improve the survival in these patients. Mid-stage study results presented at the European Society for Medical Oncology congress indicated that cetuximab(Erbitux) … Continue reading
Posted in Breast cancer, Cancer
Tagged Cetuximab, Cisplatin, disease progression, Erbitux, Survival, triple negative breast cancer
Comments Off on Cetuximab (Erbitux) Reduces Disease Progression in Triple Negative Breast Cancer
Novel Agent Significantly Improves Survival in Men with Advanced Prostate Cancer
Great news for patients with advanced prostate cancer. A new investigational agent, abiraterone acetate, was shown to significantly improved survival in men with metastatic castration-resistant prostate cancer. Abiraterone acetate is an investigational agent being developed by Ortho Biotech. It acts … Continue reading
Posted in Cancer, Prostate cancer
Tagged abiraterone, androgen, castration-resistant, CYP17, docetaxel, Ortho Biotech, prednisone, Prostate cancer, Survival
Comments Off on Novel Agent Significantly Improves Survival in Men with Advanced Prostate Cancer
Coffee Drinking Reduces the Risk of Oral Cavity/Pharynx Cancers
In the past, data on the relation between coffee drinking and upper digestive tract cancer risk were scattered and inconclusive. A team of researchers, therefore, conducted a systematic analysis on the relationship between coffee drinking and the risk of different … Continue reading
Posted in Cancer, Esophageal Cancer, Head and Neck Cancer
Tagged coffee, Esophageal Cancer, larynx cancer, oral cavity cancer, pharynx cancer
1 Comment
Alzheimer’s disease – Causes, Symptoms, Diagnosis, Prognosis and Latest Treatment
Alzheimer’s disease (AD) is an irreversible, progressive brain disorder that occurs gradually and results in memory loss, behavior changes, and a decline in cognitive abilities. These losses are related to the death of brain cells and the breakdown of the … Continue reading
Posted in Dementia
Tagged Alzheimer's disease, Aricept, Causes, cholineseterase inhibitor, Cognex, Dementia, Diagnosis, donepezil, Exelon, galantamine, Galanthus nivalis, glaucoma, Mini-Mental State Exam, muscular dystrophy, myasthenia gravis, neuritis, Novalin, Prognosis, Reminyl, rivastigmine, snowdrop flower, Symptoms, tacrine, Treatment
Comments Off on Alzheimer’s disease – Causes, Symptoms, Diagnosis, Prognosis and Latest Treatment
Hyperprolactinemia – Causes, Symptoms, Prognosis, Diagnosis and Latest Treatment
Hyperprolactinemia is one of the most common pituitary abnormalities, which is caused by an increased secretion of prolactin (above 20ng/ml) from the pituitary gland. Although the disorder is detected in less than 1% of the general population, it has been … Continue reading
Posted in Others
Tagged acromegaly, amenorrhea, Causes, clozapine, Diagnosis, dopamine, Dostinex, galactorrhea, Hyperprolactinemia, hypothyroidism, Infertility, methyldopa, metoclopramide, Parkinson's disease, Parlodel, phenothiazine derivates, Prognosis, prolactinomas, Symptoms, Treatment
Comments Off on Hyperprolactinemia – Causes, Symptoms, Prognosis, Diagnosis and Latest Treatment
FDA Approves Pegloticase (Krystexxa) for Refractory Gout
Good news for patients with gout. The US Food and Drug Administration (FDA) has just approved a new agent, pegloticase (Krystexxa) for gout patients who are refractory to conventional therapy. The approval was based on data from 2 replicate, multicenter, … Continue reading
Posted in Others
Tagged colchicine, Gout, Krystexxa, Pegloticase, tophi, uric acid
Comments Off on FDA Approves Pegloticase (Krystexxa) for Refractory Gout
History of Gout is linked to an Increase Risk of Heart Failure Events
It has been known that gout increases the risk of ischemic heart disease and mortality. A new study showed that gout is also associated with an increase risk of heart-failure hospitalization and death. In Montreal, Quebec, Canadian researchers performed an … Continue reading
Posted in Cardiovascular disease, Heart attack, Heart failure, Others
Tagged allopurinol, Gout, Heart Failure, hospitalizations, Ischemic heart disease
Comments Off on History of Gout is linked to an Increase Risk of Heart Failure Events
